A study to assess therapeutic equivalence between test EMLA patch with marketed EMLA patch in healthy subjects.

Trial Identifier:	D069GC00001
Sponsor:	AstraZeneca
Collaborator:	PAREXEL International GmbH
NCTID::	NCT03313336
Start Date:	October 2017
Primary Completion Date:	November 2017
Study Completion Date:	November 2017
Condition:	Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation
	German Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Germany	Berlin, Germany, 14050

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.